Top Suppliers:I want be here

360-63-4

360-63-4 structure
360-63-4 structure

Name (11β,16β)-9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4 -dien-21-yl dihydrogen phosphate
Synonyms dexamethasone-21-phosphate
Dexamethasone phosphate
Dexamethasone-21-dihydrogen-phosphate
Betnelan phosphate
Neodecadron
Wymesone
Oradexon phosphate
Dexamethasone 21-orthophosphate
Hexadrol phosphate
Density 1.45g/cm3
Boiling Point 669.6ºC at 760mmHg
Molecular Formula C22H30FO8P
Molecular Weight 472.44100
Flash Point 358.7ºC
Exact Mass 472.16600
PSA 151.17000
LogP 2.01270
Index of Refraction 1.594

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TU4055500
CHEMICAL NAME :
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-, 21-(dihydrogen phosphate)
CAS REGISTRY NUMBER :
360-63-4
LAST UPDATED :
198612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C22-H30-F-O8-P

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 21,587,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 21,587,1966